NG Anesthésie
ActiveFrom the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
NG Anesthésie has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16,853 and a net result of €13,853. The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Official details
KBO- Status
- Active since 08-07-2025 Normal situation
- Activity
- “L’exercice de l’art médical au sens large et plus particulièrement dans le domaine de…” (deed in French)From the articles, 4 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.376.095.568 6717 Attert, since 08-07-2025
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.6%
- Gross margin
- €19,136
- Turnover
- ≈ €150,000
- estimated
- Profit
- €13,853
- Equity
- €16,853
- Total assets
- €22,741
Score breakdownraises riskFounded in 2025No main activity registeredlowers riskLiquidity: current ratio 3.86, cash €22,281Equity €16,853 (74.1% of total assets)Show the evidence
Checked score
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 62% of them on solvency, 81% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 06-06-2026
Acts in the Belgian Official Gazette
- Incorporationact of 10-07-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about NG Anesthésie
- What is the company number of NG Anesthésie?
- The company number of NG Anesthésie is 1025.289.406. The VAT number is the same number with BE in front: BE 1025.289.406.
- Where is NG Anesthésie based?
- The registered office is at Rue du Fourneau,Post 239, 6717 Attert.Company details
- What is the legal form of NG Anesthésie?
- The legal form of NG Anesthésie is Private limited company (BV).
- When was NG Anesthésie founded?
- NG Anesthésie was founded on 08-07-2025.
- Is NG Anesthésie still active?
- Yes, NG Anesthésie is an active enterprise in the KBO register.
- What is the turnover of NG Anesthésie?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €19,136 and 6,330 comparable companies of the same size. It probably lies between €67,000 and €350,000. It is a rough estimate.Financials
- Is NG Anesthésie profitable?
- In financial year 2025, NG Anesthésie made a profit of €13,853.
- Where can I find the annual accounts of NG Anesthésie?
- NG Anesthésie filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank
Next steps
See how customers, suppliers and banks see your own company and what to improve first.